Protein Engineering Market to Reach $7.7 Billion, Globally, by 2032 at 13.2% CAGR: Allied Market Research

Rise in prevalence of chronic disorders, surge in technological advancements, and rise in demand for protein engineered therapeutics drive the growth of the global protein engineering market.

PORTLAND, Ore., Dec. 6, 2023 /PRNewswire/ -- Allied Market Research published a report, titled, "Protein Engineering Market by Product (Instruments, Consumables, and Software), Technology Type (Rational/ Site Directed Mutagenesis and Irrational/ Random Mutagenesis), Protein Type (Monoclonal Antibodies, Insulin, Erythropoietin, Interferon, and Others), and End User, (Pharmaceutical & Biotechnological Companies, Academic & Research Institutes, and Contract Research Organizations): Global Opportunity Analysis and Industry Forecast, 2023-2032". According to the report, the global protein engineering industry generated $2.2 billion in 2022, and is anticipated to generate $7.7 billion by 2032, witnessing a CAGR of 13.2% from 2023 to 2032.

Request Sample of the Report on Protein Engineering Market Forecast 2032- https://www.alliedmarketresearch.com/request-sample/1129 

Prime determinants of growth

Increasing R&D activities in the biopharmaceutical industry, technological advancements in protein engineering, and increase in developmental strategies in protein engineering by key players drive the growth of the global protein engineering market. However, high cost and maintenance of protein engineering systems restricts the market growth. Moreover, the growth opportunities in emerging markets presents new opportunities in the coming years.

Report coverage & details:

Economic Downturn Analysis: Impact of Recession in 2023 on the Protein Engineering Market

• During economic downturns, there is a heightened focus on cost containment and efficient resource allocation. Recessions often result in budget cuts, impacting research funding from both public and private sectors. Reduced funding affects academic institutions, research centers, and biotechnology companies engaged in life sciences research.
• Moreover, it hampers investments in protein engineering technology development, slowing down innovation and the introduction of advanced protein engineering systems.
• However, despite budget constraints, the significance of healthcare research remains pivotal, especially during challenging times. Diseases and health concerns persist regardless of economic conditions, potentially leading to sustained demand for protein engineering technologies in critical areas such as disease research, diagnostics, and drug development.

Want to Explore More, Connect to our Analyst- https://www.alliedmarketresearch.com/connect-to-analyst/1129 

The consumables segment to maintain its leadership status during the forecast period

By product, the consumables segment held the largest market share in 2022, accounting for nearly half of the global protein engineering market revenue and is estimated to maintain its leadership status during the forecast period. This is attributed to rise in demand for consumables, along with a wide range of available consumables.

However, the instruments segment is projected to attain the highest CAGR of 13.7% from 2023 to 2032. This is attributed to the continuous technological innovations in protein engineering systems.

The rational/site-directed mutagenesis segment to maintain its leadership status during the forecast period

By technology type, the rational/site-directed mutagenesis segment held the largest market share in 2022, accounting for nearly three-fifths of the global protein engineering market revenue and is estimated to maintain its leadership status duing the forecast period. This is attributed to its wide application such as to enhance thermal stability or resistance to denaturation of a protein, to alter the substrate or ligand specificity of enzymes or binding proteins by targeted changes in key amino acid residues.

However, the irrational/random mutagenesis segment is projected to attain the highest CAGR of 13.7% from 2023 to 2032. This is attributed to various applications of random mutagenesis such as, it is used in directed evolution experiments to generate diverse libraries of protein variants, which can then be screened for improved or novel functions as well as it is also used to exploring sequence-function space to identify variants with desired traits.

The monoclonal antibodies segment to maintain its leadership status during the forecast period

By protein type, the monoclonal antibodies segment held the largest market share in 2022, accounting for more than two-fifths of the global protein engineering market and is estimated to maintain its leadership status during the forecast period. This is attributed to increase in demand for personalized medicine and the target therapy of monoclonal antibodies, which is anticipated to increase the popularity of this market.

However, the insulin segment is projected to attain the highest CAGR of 14.4% from 2023 to 2032, owing to increase in prevalence of type 1 and type 2 diabetes.

The pharmaceutical and biotechnology companies' segment to maintain its lead position during the forecast period

By end user, the pharmaceutical and biotechnology companies segment accounted for the largest share in 2022, contributing to nearly half of the global protein engineering market revenue, and is projected to maintain its lead position during the forecast period. This is attributed to a substantial investment in research, propelling the demand for cutting-edge protein engineering technologies.

However, the contract research organization segment is projected to attain the highest CAGR of 13.5% from 2023 to 2032 as contract research organizations (CROs) play a significant role in providing R&D services to pharmaceutical, biotechnology, and academic institutions.

For Procurement Information- https://www.alliedmarketresearch.com/purchase-enquiry/1129 

North America to maintain its dominance by 2032

Region-wise, North America held the largest market share in terms of revenue in 2022, accounting for nearly two-fifths of the global protein engineering market revenue, and is expected to dominate the market during the forecast period. This is attributed to the well-established healthcare system, rise in prevalence of chronic diseases, technological advancement in devices, and rise in number of product approvals.

However, the Asia-Pacific region is expected to witness the fastest CAGR of 14.0% from 2023 to 2032. Rise in the prevalence of chronic diseases in the Asia-Pacific region, such as cancer, cardiovascular disorders, and diabetes, which necessitates advanced therapeutics, is expected to drive the growth of the protein engineering market in the region.

Leading Market Players:

• Agilent Technologies, Inc.
• Thermo Fisher Scientific Inc.
• Takara Holdings, Inc.
• Promega Corporation
• New England Biolabs
• Jena Bioscience GmbH
• Danaher Corporation
• Creative Biolabs
• Amgen, Inc.
• Bio-Rad Laboratories, Inc.

The report provides a detailed analysis of these key players in the global protein engineering market. These players have adopted strategies such as product launch, product approval, acquisition, agreement, and partnership to increase their market share and maintain dominant shares in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario.

Comprehensive Healthcare Industry Research Studies:

Dysphagia Supplement Market - Global Opportunity Analysis and Industry Forecast, 2022–2032

Portable Dental Chair Market - Global Opportunity Analysis and Industry Forecast, 2022-2032

Genetic Testing Market - Global Opportunity Analysis and Industry Forecast, 2022-2032

TAVR Embolic Protection Market- Global Opportunity Analysis and Industry Forecast, 2022–2032

Hearing Implants Market - Global Opportunity Analysis and Industry Forecast, 2022–2032

Surgical Gloves Market- Global Opportunity Analysis and Industry Forecast, 2022–2032

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact
David Correa
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Toll Free: +1-800-792-5285
Int'l: +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com  
Follow Us on: LinkedIn Twitter

Logo: https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg